Your Planet Sustainable?Your Tribe Harmonious?Your Life Vibrant?
Future Proof Ideas since 2005, by Erwin van Lun

Wetenschappelijk onderzoek Bemer fysische vaattherapie

Bemer en WetenschapDit artikel geeft een overzicht van het belangrijkste wetenschappelijk onderzoek met Bemer fysische vaattherapie. Sinds de technologische doorbraak met de introductie van de Bemer Classic en Bemer Pro in 2010 (die de Bemer 3000 vervingen) is het aantal wetenschappelijke studies snel gestegen. Nieuwe onderzoek bevat ook placebo en dubbelblind geteste experimenten.

Universitair onderzoek, studies en wetenschappelijke publicaties voor Bemer

Op PubMed, dé leidende database waar alle universiteiten, instituten en artsen hun informatie in publiceren en in opzoeken, zijn de volgende vijf studies opgenomen over Bemer (soms nog afgekort als Bio-Electromagnetic- Energy-Regulation BEMER).


  • Effects of various physical treatment methods on arteriolar vasomotion and microhemodynamic functional characteristics in case of deficient regulation of organ blood flow. Results of a placebo-controlled, double-blind study.
    Journal: J Complement Integr Med. 2013;10(Suppl):S39-46, S41-9. doi: 10.1515/jcim-2013-0035.
    [Article in English, German]
    Klopp RC, Niemer W, Schmidt W.
    As part of a placebo-controlled study, high-resolution measurement methods were used to examine, on the basis of representative functional characteristics of microcirculation, whether and to what extent six different, commercially available, physical treatment devices were suitable for influencing, through complementary therapy, deficient blood-flow regulation. Of the six commercially available devices tested, two proved to be ineffective and three not effective enough to be therapeutically relevant. Only in one device was it possible to show a complementary-therapeutic effect: the device uses a specific, biorhythmically defined stimulus for vasomotion.
    In het volledige artikel is te lezen dat het hier gaat om het Bemer systeem. Dit artikel is toegankelijk op PubMed voor artsen, professoren en andere onderzoekers.
  • Complementary-therapeutic stimulation of deficient autorhythmic arteriolar vasomotion by means of a biorhythmically physical stimulus on the microcirculation and the immune system in 50-year-old rehabilitation patients Journal: J Complement Integr Med. 2013;10(Suppl):S29-37, S31-9. doi: 10.1515/jcim-2013-0034.
    [Article in English, German]
    Auteurs: Klopp RC, Niemer W, Schulz J.
    As part of a placebo-controlled study series, a random sample of 50-year-old rehabilitation patients was examined to determine whether the complementary use of a physical treatment method to stimulate arteriolar vasomotion would improve the therapeutic success of established measures for the purposes of physical conditioning. The result showed that both the microcirculatory blood-flow regulation and the (cellular) immune response could be affected in a therapy-relevant manner through additional physical vasomotion stimulation.
  • Effects of physical stimulation of spontaneous arteriolar vasomotion in patients of various ages undergoing rehabilitation
    Journal: J Complement Integr Med. 2013;10(Suppl):S13-9, S15-21. doi: 10.1515/jcim-2013-0032.
    [Article in English, German]
    Auteurs: Klopp RC, Niemer W, Schulz J.
    On two samples of rehabilitation patients of different age groups (approx. 38 years and approx. 51 years), via a placebo-controlled study series using representative features of microcirculation, the complementary therapeutic success of additional treatment complementing the biorhythmically defined physical vasomotion stimulation was determined. The results showed that in older rehabilitation patients the amounts of characteristic microcirculatory changes were greater than in younger persons undergoing rehabilitation, but they would subside faster after termination of the additional treatment than in the younger group.
  • The effects of the ‘physical BEMER® vascular therapy’, a method for the physical stimulation of the vasomotion of precapillary microvessels in case of impaired microcirculation, on sleep, pain and quality of life of patients with different clinical pictures on the basis of three scientifically validated scales.
    Journal: J Complement Integr Med. 2013;10(Suppl):S5-12, S5-13. doi: 10.1515/jcim-2013-0037.
    [Article in English, German]
    auteurs: Bohn W, Hess L, Burger R.
    As part of the statutory market monitoring of certified medical devices, 658 valid patient questionnaires were evaluated between April 2011 and March 2013. The questions consisted mainly of three scientifically recognized scales for assessing the changes of sleep, pain and quality of life in patients who had used the “physical BEMER® vascular therapy” for different diseases over 6 weeks. The result clearly shows that there are significant improvements in all areas surveyed through the application of this complementary treatment option, regardless of the underlying disease.
    Termen: Adult | Aged | Complementary Therapies/methods | Female | Humans | Male | Microcirculation |Microvessels/physiopathology | Middle Aged | Pain | Physical Stimulation | Quality of Life | Sleep | Sleep Disorders/therapy
  • Influence of a specific, biorhythmically defined physical stimulus on deficient vasomotion in small-caliber arterioles in the subcutis in patients with diabetic polyneuropathy.
    journal: J Complement Integr Med. 2013;10(Suppl):S21-7, S23-9. doi: 10.1515/jcim-2013-0033.
    [Article in English, German]
    auteurs: Klopp RC, Niemer W, Schulz J, Ruhnau KJ.
    As part of a placebo-controlled study series on a random sample of patients with diabetic polyneuropathy and trophic skin lesions on the edge of the foot, functional characteristics of the local microcirculation and immune system were measured to check the complementary-therapy success of biorhythmically defined vasomotion stimulation. Over a 30-day treatment period, complementary-therapy success was demonstrated for an additional physical vasomotion stimulation to increase the therapeutic success of established treatment concepts.
  • The technological development history and current significance of the “physical BEMER® vascular therapy” in medicine
    Journal: J Complement Integr Med. 2013;10(Suppl):S1-3. doi: 10.1515/jcim-2013-0036
    [Article in English, German]
    Auteur: Bohn W.
    Termen: Blood Vessels/physiology | Complementary Therapies/methods | Humans | Microcirculation | Technology

    • Ouder

      • Long-term effects of Bio-Electromagnetic-Energy Regulation therapy on fatigue in patients with multiple sclerosis
        Journal: Altern Ther Health Med. 2011 Nov-Dec;17(6):22-8.
        Auteurs: Haase R1, Piatkowski J, Ziemssen T.
        Auteur informatie: Neurological Outpatient Center, Dresden, Germany.

        Electromagnetic-field therapy has beneficial short-term effects in multiple sclerosis (MS) patients with major fatigue, but long-term data are lacking. PRIMARY STUDY OBJECTIVES: To evaluate the long-term effects of a specific electromagnetic therapy device (Bio-Electromagnetic- Energy-Regulation [BEMER]) on MS-related fatigue, we designed a crossover control of a previously performed randomized controlled trial and a long-term open-label follow-up trial. DESIGN AND SETTING:
        Crossover and open-label follow-up trials at a single neurological outpatient center.
        Patients with relapsing-remitting MS who had major fatigue (N = 37 patients).
        After a previous randomized controlled trial (exposure to low-frequency pulsed magnetic fields for 8 min twice daily or to placebo treatment for 12 wk), a crossover from control to treatment for another 12 weeks, followed by an open label follow-up trial to 3 years, were done.
        The outcome criteria were the Modified Fatigue Impact Scale (MFIS), Fatigue Severity Scale (FSS), German long version of the Center for Epidemiologic Studies Depression Scale (CES-D), Multiple Sclerosis Functional Scale (MSFC), and Expanded Disability Status Scale (EDSS).
        Patients previously on placebo during the randomized controlled trial experienced significant reductions in fatigue after crossing over to treatment. The MFIS and FSS scores were significantly lower in the open-label group than in the control subjects after follow-up. Participation in the open-label treatment was the strongest predictor of low fatigue outcome after followup. Electromagnetic-field therapy was well tolerated.
        In this long-term study, a beneficial effect of long-term BEMER therapy on MS fatigue was demonstrated. Electromagnetic-field therapy may be a useful therapeutic modality in MS patients with severe fatigue.
        Termen: Adult | Cross-Over Studies | Electromagnetic Fields | Fatigue/etiology | Fatigue/prevention & control | Fatigue/therapy | Female | Humans | Male | Middle Aged | Multiple Sclerosis, Relapsing-Remitting/complications | Multiple Sclerosis, Relapsing-Remitting/prevention & control | Multiple Sclerosis, Relapsing-Remitting/therapy | Muscle Spasticity/rehabilitation | Pain/etiology | Pain/prevention & control | Quality of Life | Research Design | Severity of Illness Index | Treatment Outcome




Alle Bemer postings